FOLD Fail-to-Deliver

Amicus Therapeutics, Inc. (FOLD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.55B, listed on NASDAQ, employing roughly 499 people, carrying a beta of 0.48 to the broader market. Amicus Therapeutics, Inc. Led by Bradley L. Campbell, public since 2007-05-31.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-04-28

Latest FTD Quantity

3.5K

Latest Price

$14.49

30-Day Avg FTD

286.4K

30-Day Total FTD

8.6M

Showing 30 days of SEC fail-to-deliver data for Amicus Therapeutics, Inc..

Learn how fails-to-deliver is reported and how to read the data →